Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2004 1
2005 1
2006 2
2007 5
2008 5
2009 7
2010 10
2011 9
2012 4
2013 7
2014 12
2015 11
2016 12
2017 4
2018 13
2019 18
2020 26
2021 19
2022 21
2023 19
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

172 results

Results by year

Filters applied: . Clear all
Page 1
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer.
Tilki D, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, Eberli D, De Meerleer G, De Santis M, Farolfi A, Gandaglia G, Gillessen S, Grivas N, Henry AM, Lardas M, J L H van Leenders G, Liew M, Linares Espinos E, Oldenburg J, van Oort IM, Oprea-Lager DE, Ploussard G, Roberts MJ, Rouvière O, Schoots IG, Schouten N, Smith EJ, Stranne J, Wiegel T, Willemse PM, Cornford P. Tilki D, et al. Among authors: j l h van leenders g. Eur Urol. 2024 Apr 29:S0302-2838(24)02306-6. doi: 10.1016/j.eururo.2024.04.010. Online ahead of print. Eur Urol. 2024. PMID: 38688773 Review.
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.
Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, Eberli D, De Meerleer G, De Santis M, Farolfi A, Gandaglia G, Gillessen S, Grivas N, Henry AM, Lardas M, van Leenders GJLH, Liew M, Linares Espinos E, Oldenburg J, van Oort IM, Oprea-Lager DE, Ploussard G, Roberts MJ, Rouvière O, Schoots IG, Schouten N, Smith EJ, Stranne J, Wiegel T, Willemse PM, Tilki D. Cornford P, et al. Among authors: van leenders gjlh. Eur Urol. 2024 Apr 12:S0302-2838(24)02254-1. doi: 10.1016/j.eururo.2024.03.027. Online ahead of print. Eur Urol. 2024. PMID: 38614820 Review.
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer.
Rijnders M, Nakauma-González JA, Robbrecht DGJ, Gil-Jimenez A, Balcioglu HE, Oostvogels AAM, Aarts MJB, Boormans JL, Hamberg P, van der Heijden MS, Szabados BE, van Leenders GJLH, Mehra N, Voortman J, Westgeest HM, de Wit R, van der Veldt AAM, Debets R, Lolkema MP. Rijnders M, et al. Among authors: van leenders gjlh. Nat Commun. 2024 Feb 14;15(1):1349. doi: 10.1038/s41467-024-45714-0. Nat Commun. 2024. PMID: 38355607 Free PMC article.
Does prostate cancer without cribriform pattern have metastatic potential?
Kroon LJ, Remmers S, Hollemans E, Bangma CH, Roobol MJ, van Leenders GJLH. Kroon LJ, et al. Among authors: van leenders gjlh. Prostate Cancer Prostatic Dis. 2024 Feb 10. doi: 10.1038/s41391-024-00802-6. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 38341462 Review. No abstract available.
Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools.
Downes MR, Liu KN, Yu Y, Lajkosz K, Kroon LJ, Hollemans E, Fleshner N, Finelli A, van Leenders GJLH, Iczkowski KA, van der Kwast TH. Downes MR, et al. Among authors: van leenders gjlh. Clin Genitourin Cancer. 2024 Feb;22(1):47-55. doi: 10.1016/j.clgc.2023.07.013. Epub 2023 Aug 1. Clin Genitourin Cancer. 2024. PMID: 37558528
172 results